CERUS CORP Net Fee Amt
CERUS CORP (CERS) had Net Fee Amt of $3.98 thousand as of 2026-07-30, per its S-8 filed 2026-07-30.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-07-30
- 2026-07-30: Net Fee Amt $3.98K.
| Period end | Net Fee Amt |
|---|---|
| 2026-07-30 | $3.98K S-8 · filed 2026-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |